Back to Journals乐动体育西班牙人 » Pharmacogenomics and Personalized Medicine

Pharmacogenomics and Personalized Medicine


ISSN: 1178-7066

Editor-in-Chief: Dr Martin H Bluth

乐动体育西班牙人An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. 

This journal is a member of and subscribes to the principles of the (COPE). 

Journal Impact Factor: 2.721

Indexed online:

  • Science Citation Index Expanded
  • Journal Citation Reports/Science Edition
  • Biological Abstracts
  • BIOSIS Previews
  • Emerging Sources Citation Index (ESCI), from 2016
  • and PubMed Central (Pharmgenomics Pers Med
  • Embase, from 2009 (Correct as at December 8, 2016)
  • Scopus, from 2009 (Correct as at December 8, 2016)
  • : The Open Access Initiative